Penelope Andreux
29Patents
6h-index
21Co-inventors
65Inventor score
Filing activity: Dec 23, 2011 → Jan 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9872850B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 12 | Active |
| US10485782B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 10 | Active |
| US10028932B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US10857126B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 8 | Active |
| US9962366B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 7 | Active |
| US10988453B2 | Compositions comprising an urolithin compound | Human Necessities | 7 | Active |
| US11166972B2 | Compositions comprising nicotinamide riboside and a urolithin | Human Necessities | 6 | Active |
| US10442784B2 | Compositions comprising an urolithin compound | Human Necessities | 6 | Active |
| US11166937B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11234960B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11020373B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 5 | Active |
| US10792276B2 | Urolithins as immune response enhancers | Emerging Cross-Sectional Technologies | 5 | Active |
| US10695320B2 | Compositions comprising urolithin compounds | Chemistry; Metallurgy | 5 | Active |
| US11820751B2 | Urolithin derivatives and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11426380B2 | Urolithins as immune response enhancers | Emerging Cross-Sectional Technologies | 1 | Active |
| US11337957B2 | Compositions comprising urolithin compounds | Chemistry; Metallurgy | 1 | Active |
| US11878964B2 | Compositions comprising an urolithin compound | Human Necessities | 1 | Active |
| US12036205B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US11903922B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US12310943B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US12297182B2 | Compositions comprising an urolithin compound | Human Necessities | 0 | Active |
| US12351567B2 | Urolithin derivatives and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11969408B2 | Method for improving mitophagy in subjects | Chemistry; Metallurgy | 0 | Active |
| US11931335B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 0 | Active |
| US12358884B2 | Urolithin derivatives and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.